Kevin Michael O'Neill - 03 Jan 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, PDx
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Issuer symbol
GEHC
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 19:45:21 UTC
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common stock, par value $0.01 per share Award +59 59 03 Jan 2023 By share incentive plan trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award +1,653 1,653 04 Jan 2023 Common stock, par value $0.01 per share 1,653 $129.52 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +343 343 04 Jan 2023 Common stock, par value $0.01 per share 343 $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +3,329 3,329 04 Jan 2023 Common stock, par value $0.01 per share 3,329 $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +3,672 3,672 04 Jan 2023 Common stock, par value $0.01 per share 3,672 $135.92 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +5,051 5,051 04 Jan 2023 Common stock, par value $0.01 per share 5,051 $161.30 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +5,877 5,877 04 Jan 2023 Common stock, par value $0.01 per share 5,877 $99.21 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +4,592 4,592 04 Jan 2023 Common stock, par value $0.01 per share 4,592 $76.66 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +13,275 13,275 04 Jan 2023 Common stock, par value $0.01 per share 13,275 $40.40 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +3,106 3,106 04 Jan 2023 Common stock, par value $0.01 per share 3,106 $57.74 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +1,614 1,614 04 Jan 2023 Common stock, par value $0.01 per share 1,614 $51.67 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +10,820 10,820 04 Jan 2023 Common stock, par value $0.01 per share 10,820 $63.51 Direct F1, F3
transaction GEHC Restricted Stock Units Award +1,622 1,622 04 Jan 2023 Common stock, par value $0.01 per share 1,622 Direct F1, F4, F5
transaction GEHC Restricted Stock Units Award +6,519 6,519 04 Jan 2023 Common stock, par value $0.01 per share 6,519 Direct F1, F4, F6
transaction GEHC Restricted Stock Units Award +5,568 5,568 04 Jan 2023 Common stock, par value $0.01 per share 5,568 Direct F1, F4, F7
transaction GEHC Restricted Stock Units Award +9,106 9,106 04 Jan 2023 Common stock, par value $0.01 per share 9,106 Direct F1, F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
F2 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.
F3 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is fully exercisable immediately and 50% will become exercisable on March 2, 2023.
F4 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F5 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.
F6 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.
F7 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.
F8 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.